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Abstract
There is a rise in cardiovascular diseases (CVDs) in sub-Saharan Africa (SSA). 
Even though SSA is home to 14% world’s inhabitants, it is home to more than half 
of the global poor. The objective of this chapter is to evaluate the interconnec-
tion between CVD and poverty in SSA. We found that the relationship between 
poverty and CVD is bidirectional. The intersection between poverty and CVD cuts 
through primordial, primary prevention and secondary prevention interventions. 
In the context of poverty in SSA, CVD prevention is a challenge due to competing 
demands to address the never conquered infectious diseases exacerbated by the 
current COVID-19 pandemic. With a weak healthcare system and out of pocket 
payment for the costs of CVD care, a significant proportion of individuals with 
CVD and their households are consequently impoverished. Besides, CVD affects 
a younger and productive population in SSA than in the rest of the world. Thus, 
CVD-related loss of productivity progressively pushes an additional number of 
individuals into poverty, requiring urgent attention.
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1. Introduction
Cardiovascular diseases (CVDs) include coronary heart disease, cerebrovascular 
diseases, peripheral arterial disease, rheumatic and congenital heart disease, and 
deep vein thrombosis [1]. Except for coronary heart disease on the rise in urban 
areas, hypertension, stroke, cardiomyopathies, and rheumatic heart disease are 
the most common CVDs across sub-Saharan Africa (SSA) [2, 3]. CVDs account for 
30% of global deaths, and about 80% of them occurring in low- and middle-income 
countries (LMICs), including SSA [2, 4]. By 2030, projections show that CVD 
alone will cause more SSA deaths than infectious diseases, maternal and perinatal 
conditions, and nutritional disorders combined [5]. Consequently, an increas-
ing priority area for future activities. The rising burden of CVD in SSA is due to 
increasing population exposure to various modifiable risk factors that account for 
at least three-quarters of all the CVDs [3]. The risk factors include unhealthy diets, 
physical inactivity, hypertension, obesity, diabetes, dyslipidaemia, and tobacco use 
[4]. Given the poverty and multiple competing health priorities across SSA, similar 
to several other LMICs, both prevention and treatment of CVDs get less attention 
[3]. With the high patient co-payments in many SSA countries, CVDs impose a 
significant health and economic burden on individuals and families in the region 
than in higher-income countries [6]. Above and beyond, poverty may contribute 
to an increased burden of CVD by its effect on several social and cultural factors 
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responsible for the increasing burden of CVD [7]. Consequently, this report looked 
at CVD and poverty interconnection in SSA and the implications for the future.
2. Poverty in sub-Saharan Africa
SSA is home to 14% of the 7.8 billion world’s inhabitants but contributes to 
more than half of the global poor [8, 9]. Using the 1-dimensional measurement of 
poverty that focuses on income or wealth, over 40% of SSA residents live below 
the poverty line of $1.90 per person per day [9]. This poverty level is far above the 
average poverty rate of 13% in other regions of the world [10]. While the rest of the 
world has observed a significant decline in extreme poverty, SSA observed a rise 
in the number of people living in extreme poverty from 278 million in 1990 to 413 
million in 2015 [9, 11]. Even those who live above the $1.90 poverty, a significant 
proportion of them are still very poor due to deprivations in various aspects of 
well-being [9, 11]. Using deprivation from education, health, and assets as multi-
dimensional measures of poverty, about half (51%) of the poor population in the 
world lives in SSA [12]. Therefore, most sub-Saharan inhabitants lack sufficient 
income and basic needs, including quality health and education [12]. Most of the 
causes of poverty in SSA are not different from the rest of the world. They include 
colonialism, war and political instability, national debts, discrimination and social 
inequality, and vulnerability to natural disasters [13]. The impact of colonialism, 
the slave trade and resource extraction from SSA likely contributed in some ways 
to the persistent poverty in the region [14]. The existence of a significant inequality 
in income distribution and access to productive resources, essential social services, 
opportunities, markets exacerbate the already existing poverty despite the auton-
omy of African countries following their independence [15]. Women and children 
are the most affected groups with inequalities and natural catastrophic events such 
as drought, flooding, and frequent disease epidemics in the region [14, 15]. In these 
events, the already impoverished people are often displaced, lose their belongings, 
and remain in the vicious cycle of poverty [15].
Similarly, violent regional conflicts, forced displacement and political instability 
in a significant number of SSA countries interfere with safety, stability and security 
needed for investment and economic growth [13]. The situation is made worse by 
weak national institutions permissive to corruption and resource misallocation in 
many SSA countries [9]. As a result, these countries carry significant debts that 
have high-interest rates and are linked to conditions that may be unfavourable 
to the development of local economies [13]. The impact of HIV and AIDS is also 
significant as the disease affected the working-age population leading to a reduc-
tion in economic productivity [16]. In the context of all these factors, it remains 
unclear if the region will end poverty in all its forms by 2030 as per the Sustainable 
Development Goal 1 (SDG 1) [17].
3. The effect of poverty of CVD in Africa
With poverty, SSA has the lowest healthcare expenditure, the lowest life expec-
tancy, and inadequate access to health care services, safe water, education, and 
sanitation facilities [18, 19]. Although poverty is among the reasons behind the 
region’s high burden of infectious diseases such as malaria, tuberculosis and human 
immunodeficiency virus (HIV), it is also a reason behind the rising burden of CVDs 
[4]. Economic development in SSA leads to urbanisation and increased tobacco con-
sumption, harmful alcohol use, unhealthy diets, and physical inactivity [2]. While 
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the wealthy population can revise their lifestyle, lack of access to both preventative 
and remedial health care among the poor partly explains the high burden of CVD 
risk factors [20, 21]. Besides poor access to healthcare services for CVD prevention 
and control, low education significantly affects a good understanding of the disease 
process and promoting a healthy lifestyle among the poor [22]. With poverty 
encompassing low income and consumption, poor education, health, nutrition, and 
other human development parameters, its effect on CVD is complex [23]. It affects 
different stages, ranging from primordial prevention that targets the emergence 
of CVD risk factors, primary prevention in the presence of CVD risk factors, and 
educational programmes on modifiable CVD risk factors.
Unfortunately, data on the overall burden of CVD and its association with poverty 
are scarce in SSA [24]. With the weak state of the health systems in many SSA coun-
tries, typical patient record systems are not sufficiently functional to support accurate 
morbidity and mortality data documentation [25]. Given the high burden of environ-
mentally induced risk behaviours and limited access to good-quality and affordable 
health care, the CVD burden, morbidity, and mortality are disproportionately higher 
among the poor than the affluent population in the region [20–22, 26–28]. Only a few 
countries (e.g., Botswana) have a universal healthcare system that extends coverage 
to poor communities [28]. Besides, CVD modifiable risk factors such as hypertension, 
diabetes, and cholesterol disorders remain undiagnosed or untreated in a significant 
proportion of the poor communities in SSA [28–33]. The situation is concerning 
because early detection and effective management of risk factors can substantially 
reduce most CVD [34]. Over and above the behavioural and physiological risk factors, 
anger, anxiety and depression are important risk factors for CVD [35]. Poor housing, 
sanitation and limited access to healthcare are psychosocial stressors that may lead 
to anger, anxiety and depression in the poor urban sub-Saharan populations [35]. 
Psychosocial stressors lead to an increased behavioural risk factors for CVD such as 
tobacco consumption, harmful alcohol use, unhealthy diets, and physical inactiv-
ity [2]. Also, most of these populations live in overpopulated unplanned urban 
settlements, which are often not conducive for establishing healthy behaviours [2, 
18, 19]. These communities can hardly afford healthy food and have high illiteracy 
levels [20, 21].
Hence, poverty leads to CVD through multiple ways that lie within and outside 
the health sector. Consequently, broad partnerships across various sectors are 
needed to achieve the 25% reduction in premature NCD mortality by 2025 (the 25 
by 25 goal) in SSA [36].
Although not related to the epidemiological transition, rheumatic heart disease 
(RHD) is another poverty-related CVD that has remained unconquered in SSA 
[30, 37]. The disease is responsible for over 95% of the 492 042 global deaths per 
year among the young population in SSA and other impoverished communities 
in Oceania, South Asia, Central Asia, and the Middle East [38]. SSA (5·7 cases 
per 1000), the Pacific and indigenous Australia and New Zealand (3·5 cases per 
1000), and south-central Asia (2·2 cases per 1000) are the regions with the highest 
prevalence of RHD [38]. The disease results from acute rheumatic fever (ARF) - an 
abnormal immunological response to Group A Streptococcal (GAS) infection of the 
throat [39]. Risk factors of ARF include poverty, overcrowding and reduced access 
to medical care, all prevalent in SSA [38, 40]. Primary prevention of ARF involves 
early detection and antibiotic treatment of streptococcal pharyngitis [38, 41]. Early 
detection and treatment of streptococcal pharyngitis require functional health 
care services and a community with enough health literacy and appropriate health-
seeking behaviour. With rampant poverty and the absence of universal healthcare, 
the treatment of streptococcus pharyngitis is poorly practised in many SSA coun-
tries [42]. Consequently, RHD remains prevalent in SSA versus other countries 
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and an appreciable cause of premature mortality with a mean age of death as low 
as 25 years [43]. While medical and surgical management can reduce morbidity 
and mortality, poverty reduction and improvement of overall living standards are 
crucial in reducing the overall burden and complications of RHD [44].
4. The effect of CVD on poverty in Africa
CVDs occur approximately two decades earlier in SSA than in the rest of the 
world [5]. In the context of poverty and weak healthcare systems, patients with CVD 
in SSA have higher all-cause mortality and shorter lifespans than in the other parts 
of the world due to often limited access to healthcare. Over 50% of these patients 
die between 30 and 69 years of age, approximately ten years or more below the 
equivalent group in higher-income countries [45]. Consequently, death and disability 
attributable to CVD occur in the middle and economically productive age, affecting 
young families and the much-needed workforce in the region [45, 46]. Available 
evidence implicates stroke as the cause of the majority of CVD-related mortality in 
SSA [46]. With the absence of universal health coverage and robust health insurance 
systems among most SSA countries, patients and their families bear the costs of 
CVD care costs [47]. In some instances, patients forego treatment due to costs [47]. 
The impoverishing effect of out-of-pocket payments is increasingly pushing many 
individuals and families into poverty with family members affected by CVD [6].
5. Poverty, illiteracy, and indigenous knowledge system effect on CVD
Given the high cost and inaccessibility of biomedical care and medications for CVD, 
traditional healers are central to CVD treatment among patients in SSA [48, 49]. The 
spiritual underpinning of chronic diseases such as CVD, cultural beliefs, and taboos are 
reasons behind the preference of traditional healers over biomedicine as the first choice 
in some parts of SSA [50]. Consequently, it is not uncommon for individuals in the 
region to seek help from traditional healers to treat diabetes, hypertension, and stroke 
[51–53]. The belief that traditional healers are experts in treating and curing CVDs and 
their risk factors delays the transfer to biomedical care despite the clinical deterioration 
in some patients [50]. Those who transfer to biomedical care are less likely to maintain 
treatment compliance equivalent to traditional medicines. These culturally driven 
practices present the greatest threat to the treatment and control of CVDs and their 
risk factors [50]. Some cultural ideas partly explain the persistently low knowledge 
of CVDs, risk factors, and clinical symptoms in the SSA population [54]. Therefore, 
governments and other key stakeholder groups understanding these cultural-driven 
beliefs and practices are essential in devising strategies to improve health literacy in 
managing and controlling CVDs [55].
6.  Effect of poverty on diagnosis treatment and control/eradication  
of CVD
With the growing burden of NCDs worldwide, the 2011 United Nation (UN) 
high-level meeting adopted a political declaration on NCDs that aimed at a 25% 
reduction in premature mortality from the four main NCDs (cardiovascular dis-
eases, chronic respiratory diseases, cancers, and diabetes) by 25% relative to their 
2010 levels by 2025 (the 25 × 25 target) [36]. In 2015, the UN SGD-3 was adopted 
to reduce by one-third premature mortality from NCDs by 2030 [17]. To realise 
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the SGD-3 target on health, a reduction in tobacco use, harmful alcohol use, salt 
intake, obesity, raised blood pressure, increased blood glucose and diabetes, and 
physical inactivity is essential [56]. Besides, treating people at high risk of CVD and 
ensuring a sustainable availability of medicines to treat NCDs and avoid potential 
complications is also critical [56]. The above measures are challenging to implement 
because of the regional poverty, underfunded healthcare systems and the absence 
of clear policies and strategies [57]. To overcome these challenges, governments and 
other key stakeholder groups need to instigate several measures that may reduce 
CVD morbidity and mortality, especially among the poor. These include research-
ing to assess the optimal way to help diagnose CVD early and educate patients of 
the benefits of biomedical versus traditional medical approaches alongside lifestyle 
changes. In cognisance of the high levels of illiteracy among many of these patients, 
approaches such as pictograms are helpful in enhancing understanding [36, 58]. 
In addition, for governments to produce up-to-date guidelines that are robust and 
easy to use in electronic formats, with regular monitoring of prescribing patterns to 
improve the future quality of prescribing [59, 60]. This recognises that adherence 
to prescribing guidelines is seen as a better marker of the quality of prescribing 
than current WHO/INRUD criteria [61]. Alongside this, seek to instigate policies to 
enhance access to low-cost medicines, thereby reducing costly co-payments. This 
can potentially be achieved with the help of donors and pharmaceutical companies 
and exploring the potential for local manufacturing of multiple sourced medicines 
building on concerns during the COVID-19 pandemic [61]. In the meantime, explo-
ration of the potential for aggressive procurement programmes since we have seen 
in Europe that such programmes have resulted in the prices of generic medicines 
used to manage CVD as low as 2% of pre-patent prices [62]. Issues of transport 
costs to clinics to effectively treat patients with CVD also needs to be researched 
further as lack of contact can be a significant barrier to adherence to medicines for 
NCDs [63]. In addition, exploring different methods to improve the convenience of 
medicine dispensing that reduces time off work building on current initiatives in 
South Africa and wider [27].
7. Conclusions
There are concerns about the rising burden of CVD in SSA, adding to the preva-
lent infectious diseases in the region. The increase in CVD is due to behavioural and 
metabolic risk factors resulting from the epidemiologic transition in the region. The 
intersection between poverty and CVD cuts through primordial, primary preven-
tion and secondary prevention interventions. In the context of poverty in SSA, CVD 
prevention is a challenge due to competing demands to address the never conquered 
infectious diseases. With a weak healthcare system and out of pocket payment for 
the costs of CVD care, a significant proportion of individuals with CVD and their 
households are pushed into poverty. Besides, CVD affects a younger and productive 
population in SSA than in the rest of the world.
Consequently, CVD-related loss of productivity will push an additional number 
of individuals into poverty. Because of this, appropriate strategies are needed to 
address the rising burden of CVD across SSA, and these should include activi-
ties to address poverty issues. Activities include providing available funding and 
resources for effective screening for NCDs, especially CVD and diabetes, given high 
rates of patients not being diagnosed. Alongside this, improving the access and 
availability of medicines, especially where co-payments are an appreciable issue 
among patients. Multiple channels exist, including activities of donors as well as 
increasing local production. Alongside this, enhance educational input, especially 
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for patients with low educational levels, to improve adherence rates to suggested 
lifestyle changes and prescribed medicines, which can be appreciable concerns. 
This includes a more significant role for pharmacists and nurse practitioners in 
SSA ambulatory care clinics to help diagnose and manage CVDs. Access and other 
schemes can also help to enhance the affordability of chronic medications to pre-
vent and manage CVDs, building on current schemes. Should there continue to be 
high poverty levels and lack of healthcare, including medicines, CVDs will continue 
to be a growing issue. This is not in the best interest of any key stakeholder group or 
higher income countries seeking to benefit from growing African populations. We 
will continue to monitor the situation.
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